Patient Engagement Solutions Market worth $13.7 Billion by 2019
February 15 - The patient engagement solution market is expected to reach $13.7 billion by 2019 from $5.5 billion in 2014 at a CAGR of 20% from 2014 to 2019.
Increasing demand for better clinical outcomes, rising incidence of chronic diseases, increasing efficiency of healthcare processes and reducing healthcare costs are some of the major drivers of the patient engagement solutions market. However the biggest driver of this market is the increasing number of federal healthcare mandates such as the American Recovery and Reinvestment Act of 2009 (ARRA) and the Affordable Care Act of 2010 (ACA) that stress on value-based reimbursement and the quality of treatment rather than the traditional volume-based fee for reimbursement systems. The acts also offer incentives for healthcare stakeholders who adopt patient engagement solutions, resulting in increased adoption of patient engagement solutions. The U.S. currently dominates the patient engagement solutions market and a strong growth in this region will further increase the global patient engagement solutions market.
Inquiry Before Buying:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=105975994
The providers’ end-user segment is expected to account for the largest market share of the patient engagement solutions market during the forecast period. However payers and patients in Europe and the Pacific region are lucrative revenue pockets for this market in terms of end-user solutions.
The U.S. dominates the patient engagement solutions market followed by Europe. The Asian market is relatively new to healthcare analytics however increasing HCIT adoption and growth of medical tourism in this region will drive the growth of the Asian market.
Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=105975994
The patient engagement solutions market is highly fragmented with players such as McKesson Corporation (U.S.), Medecision, Inc. (U.S.), Allscripts, Inc. (U.S.), Phytel Inc. (U.S.), Cerner Corporation (U.S.), Orion Health (New Zealand), Aetna, Inc. (U.S.), Athenahealth, Inc. (U.S.), Emmi Solutions LLC (U.S.) and GetWellNetwork, Inc. (U.S.).
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.